Persistence of Protective Antibody Titers 12-24 Months After NmVac4-A/C/Y/W-135-DT Vaccination: Follow Up Study
Completed
- Conditions
- Meningococcal MeningitisMeningococcal Infections
- First Posted Date
- 2015-07-16
- Last Posted Date
- 2016-04-12
- Lead Sponsor
- JN-International Medical Corporation
- Target Recruit Count
- 50
- Registration Number
- NCT02500511
- Locations
- 🇺🇸
IRC Clinics, Towson, Maryland, United States
Immunogenicity and Safety of Group A, C, Y & W-135 Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine
Phase 2
Completed
- Conditions
- Meningococcal MeningitisMeningococcal Infections
- Interventions
- Biological: Test VaccineBiological: US Licensed Vaccine
- First Posted Date
- 2013-07-12
- Last Posted Date
- 2015-04-23
- Lead Sponsor
- JN-International Medical Corporation
- Target Recruit Count
- 525
- Registration Number
- NCT01897402
- Locations
- 🇺🇸
Mid Atlantic Urology Associates LLC, Greenbelt, Maryland, United States
🇺🇸Chesapeake Research Group, Pasadena, Maryland, United States
🇺🇸IRC Clinics, Towson, Maryland, United States
Safety Study of Group A, C, Y & W-135 Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine for Meningitis
Phase 1
Completed
- Conditions
- Meningococcal InfectionsMeningococcal Meningitis
- Interventions
- Biological: meningococcal meningitis conjugate vaccine, quadrivalent
- First Posted Date
- 2011-11-30
- Last Posted Date
- 2013-01-14
- Lead Sponsor
- JN-International Medical Corporation
- Target Recruit Count
- 60
- Registration Number
- NCT01482052
- Locations
- 🇺🇸
Kings Cardiology Group, Hanford, California, United States
© Copyright 2025. All Rights Reserved by MedPath